5 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group

3. Shattuck Labs, Inc. (NASDAQ:STTK)

Redmile Group Stake Value: $114,534,000
Percentage of Redmile Group’s 13F Portfolio: 1.99%
Number of Hedge Fund Holders: 8
Price per Share as of Nov. 23, 2021: $9.61

Shattuck Labs, Inc. (NASDAQ:STTK) is a biotechnology company in the clinical stage. The company focuses on the development of a new class of biological medications for cancer and autoimmune illnesses. Out of the hedge funds being tracked by Insider Monkey, Redmile Group is a leading shareholder in Shattuck Labs, Inc., with 5.62 million shares worth more than $114.53 million.

The company declared financial data for the third quarter in November. It posted revenue of $1.9 million, missing the estimates by $0.08 million. However, the company’s EPS came in at -$0.41, surpassing the market predictions by $0.03.

As of Q3 2021, 8 hedge funds tracked by Insider Monkey have positions in Shattuck Labs, Inc., up from 6 in the previous quarter. The total value of these stakes is $208.04 million.